Combinatorial peptide-based epitope mapping from Ebola virus DNA vaccines and infections reveals residue-level determinants of antibody binding

Ebola virus (EBOV) infection is highly lethal and results in severe febrile bleeding disorders that affect humans and non-human primates. One of the therapeutic approaches for treating EBOV infection focus largely on cocktails of monoclonal antibodies (mAbs) that bind to specific regions of the EBOV...

詳細記述

書誌詳細
出版年:Human Vaccines & Immunotherapeutics
主要な著者: Daniel R. Ripoll, Daniel A. J. Mitchell, Lesley C. Dupuy, Anders Wallqvist, Connie Schmaljohn, Sidhartha Chaudhury
フォーマット: 論文
言語:英語
出版事項: Taylor & Francis Group 2017-12-01
主題:
オンライン・アクセス:http://dx.doi.org/10.1080/21645515.2017.1360454

類似資料